Trade CRMD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
CorMedix Inc. (CRMD) is trading at US$8.32, up 0.13% today as of Aug 28, 09:54 EDT. The company has a market capitalisation of US$639.14M. Over the past 52 weeks, CRMD has traded between US$6.13 and US$14.96. On Syfe you can trade CRMD with $0 commission and add it to your watchlist.
| Previous close | US$8.31 |
|---|---|
| Market cap | US$639.14M |
| P/E ratio | 40.28 |
| 52-week range | US$6.13 – US$14.96 |
| Volume | 700.98K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CorMedix Inc.
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
Year: 2010
RBC Capital Trims CorMedix Price Target to $13 From $14, Maintains Outperform Rating
Jul 7, 11:58 AM · MT Newswires
CorMedix Names Elizabeth Hurlburt as Chief Operating, Commercial Officer
Jul 2, 8:51 PM · MT Newswires
CorMedix Inc. (CRMD) stock is trading at US$8.32, +0.13% from the previous close of US$8.31.
The market cap for CorMedix Inc. (CRMD) stock is approximately US$639.14M.
The price-to-earnings ratio for CorMedix Inc. (CRMD) is 40.28, based on the latest reported earnings.
The 52-week high for CorMedix Inc. (CRMD) stock is US$14.96.
The 52-week low for CorMedix Inc. (CRMD) stock is US$6.13.
CorMedix Inc. (CRMD) does not currently pay a dividend.
Stay on top of CRMD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
